Multiple myeloma is still considered as the second most prevalent haematological malignancy and despite recent progresses in treatment options, MM still remains fatal for most patients.
The aim of this study is the identification of key molecules in the bone marrow micro environment that support the disease and also to identify the potential therapeutic targets.
Effective start/end date1/01/1031/12/10

    Research areas

  • Stem Cell, Blood, Coagulation, Myeloma, Immunology, Microbiology, HLA, Hematology, Lymphoma, cancer, Bone Marrow Transplantation

    Flemish discipline codes

  • Basic sciences
  • Biological sciences

ID: 3323725